Heartflow, Inc., a Mountain View, CA-based chief in AI expertise for coronary artery illness (CAD), acquired extra investments of roughly $98m by the sale and issuance of convertible notes by its guardian firm, Heartflow Holding, Inc.
This included new funding by Constancy Administration & Analysis Firm and extra investments from current traders together with Janus Henderson Traders, Bain Capital Life Sciences, Hayfin, US Enterprise Companions (USVP), HealthCor, Capricorn Funding Group and Martis Capital. Sure members of Heartflow administration and the Board of Administrators additionally participated within the financing.
Proceeds from the convertible notes financing will assist analysis and growth efforts to additional assist Heartflow’s continued development of the coronary computed tomography angiography (CCTA)+Heartflow pathway because the definitive normal for the non-invasive analysis and administration of CAD.
Led by John Farquhar, president and CEO, Heartflow is advancing coronary care by remodeling coronary artery illness right into a screenable, diagnosable, and manageable situation. Heartflow One is a non-invasive, precision coronary care platform offering affected person insights all through the guideline-directed CCTA pathway. The AI-driven platform – together with Roadmap™ Evaluation, FFRCT Evaluation and Plaque Evaluation – is supported by the ACC/AHA Chest Ache Guideline and backed by greater than 600 peer-reviewed publications. Heartflow has helped clinicians handle over 400,000 sufferers worldwide.
FinSMEs
27/03/2025
